Literature DB >> 2640084

Ophthalmological aspects in patients with Werner's syndrome.

K W Ruprecht1.   

Abstract

In ten of 18 eyes from nine patients with Werner's syndrome, cataract surgery was complicated by wound dehiscence and its consequences: peripheral anterior synechiae (4), secondary epiretinal gliosis (4), cystoid macular edema (3) in the framework of Hruby-Irvine-Gass syndrome, unplanned filtering bleb (2), and post-operative anterior ischemic optic neuropathy (1). Additionally, corneal endothelial decompensation occurred in eight eyes. In view of the fibroblasts' reduced growth potential, we suggest small surgical incisions, extracapsular cataract surgery using phacoemulsification, intraocular irrigation solutions protecting corneal endothelium, nonabsorbable single knot sutures not removed before 1 year after surgery, and no local or systemic use of cortisone.

Entities:  

Mesh:

Year:  1989        PMID: 2640084     DOI: 10.1016/0167-4943(89)90045-9

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  3 in total

1.  Lack of association of the WRN C1367T polymorphism with senile cataract in the Israeli population.

Authors:  M Ehrenberg; O Dratviman-Storobinsky; B R Avraham-Lubin; N Goldenberg-Cohen
Journal:  Mol Vis       Date:  2010-08-28       Impact factor: 2.367

2.  Endothelial cell study in a case of Werner's syndrome undergoing phacoemulsification and Yettrium-Aluminum-Garnet laser capsulotomy.

Authors:  Vasudha Kemmanu; Somshekar Nagappa; Kaushik Hegde; Naresh K Yadav; Bhujang K Shetty
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

3.  Werner syndrome with refractory cystoid macular edema and immunohistochemical analysis of WRN proteins in human retinas.

Authors:  Toshiyuki Oshitari; Masayasu Kitahashi; Satoshi Mizuno; Takayuki Baba; Mariko Kubota-Taniai; Minoru Takemoto; Koutaro Yokote; Shuichi Yamamoto; Sayon Roy
Journal:  BMC Ophthalmol       Date:  2014-03-12       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.